BRIEF published on 10/20/2026 at 07:05, 15 days 20 hours ago Innate Pharma Announces Conference Call on its Portfolio and Finances Conference Call Financial Situation Innate Pharma Immunothérapies Marseille
PRESS RELEASE published on 09/17/2026 at 07:00, 1 month 17 days ago Inside Information / Other news releases
BRIEF published on 09/16/2026 at 22:05, 1 month 18 days ago Innate Pharma and Sobi Partnership Becomes Effective Innate Pharma Lacutamab Sobi Partnership TELLOMAK-3 Study T-cell Lymphoma
BRIEF published on 09/16/2026 at 22:05, 1 month 18 days ago Innate Pharma and Sobi formalize their partnership Strategic Partnership Innate Pharma Phase 3 TELLOMAK-3 Sobi T-cell Lymphomas
PRESS RELEASE published on 09/16/2026 at 22:00, 1 month 18 days ago Inside Information / Other news releases Innate Pharma and Sobi partnership becomes effective after meeting closing conditions, triggering USD 75 million payment and commencing TELLOMAK-3 Phase 3 study in Q1 2027 Partnership Innate Pharma Closing Conditions Sobi TELLOMAK-3
BRIEF published on 09/10/2026 at 07:05, 1 month 24 days ago Innate Pharma announces a conference on its half-year results Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
BRIEF published on 09/10/2026 at 07:05, 1 month 24 days ago Innate Pharma to Provide Financial Insights in Upcoming Conference Call Conference Call Business Strategy Financial Update Innate Pharma 2026 Results
PRESS RELEASE published on 09/10/2026 at 07:00, 1 month 24 days ago Inside Information / Other news releases Innate Pharma to host conference call on September 17, 2026, providing first half 2026 financial results and business update. Event details available on www.innate-pharma.com Financial Results Conference Call Biotechnology Business Update Innate Pharma
BRIEF published on 08/14/2026 at 11:35, 2 months 21 days ago Innate Pharma Announces Upcoming Conference Call and Webcast Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
PRESS RELEASE published on 08/14/2026 at 11:30, 2 months 21 days ago Inside Information / Other news releases Innate Pharma to host conference call and webcast with key executives discussing latest updates. Event details available on company website Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
Published on 11/04/2026 at 23:10, 4 hours 15 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 4 hours 25 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 10 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 5 hours 20 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 03:10, 14 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 3 hours 22 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 7 hours 43 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 7 hours 59 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 8 hours 41 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:00, 9 hours 24 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 17:44, 9 hours 41 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 15 hours 28 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
